+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on Highly Active Anti-Retroviral treatment in Jimma, South West Ethiopia

Prevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on Highly Active Anti-Retroviral treatment in Jimma, South West Ethiopia

Pan African Medical Journal 13: 43

Use of highly active antiretroviral therapy has led to significant reductions in morbidity and mortality rates. However, these agents had also given rise to the metabolic and morphologic abnormalities which are modifiable risk factors for cardiovascular diseases. Evidences elsewhere indicate growing in prevalence of these problems but studies are lacking in Ethiopia. This study was conducted to determine the prevalence of HIV-associated lipodystrophy and metabolic syndrome in patients taking highly active antiretroviral therapy. A cross-sectional study was conducted in 2010 on a sample of 313 patients taking highly active antiretroviral therapy in Jimma University specialized hospital. Structured questionnaire was used to assess patients' sociodemographic characteristics and clinical manifestations of metabolic abnormalities. Checklists were used for reviewing charts about clinical manifestations of metabolic abnormalities and immunologic profile of patients. Data was cleaned, entered in and analyzed using SPSS for windows version 16.0. Metabolic syndrome was detected in 21.1% and HIV-lipodystrophy was detected 12.1% of patients. The factors found to be independently associated with metabolic syndrome were taking the antiretroviral therapy for more than 12 months (AOR=4.2; 95% CI=1.24-14.23) and female sex (AOR=2.30; 95% CI=1.0-5.27) and the factor found to be independently associated with HIV-lipodystrophy was taking the antiretroviral therapy (AOR=3.59; 95% CI=1.03-12.54) for more than 12 months. Metabolic abnormalities were relatively common in the study population. The problems were higher among those who took anti-retroviral treatment for longer duration. Therefore, regular screening for and taking action against the metabolic abnormalities is mandatory.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 055159335

Download citation: RISBibTeXText

PMID: 23330034

Related references

Prevalence and factors associated with VIA positive result among clients screened at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, Ethiopia 2013: a cross-sectional study. Bmc Research Notes 8: 618, 2016

Substance use and sexually transmitted infections among anti-retroviral treatment attendees in jimma university specialized hospital, jimma, ethiopia. Ethiopian Journal of Health Sciences 22(3): 181-188, 2012

Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity. Trends in Pharmacological Sciences 26(2): 88-93, 2005

Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy. Metabolism: Clinical and Experimental 58(6): 854-859, 2009

Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia. Bmc Hematology 15: 6, 2015

Food insecurity and associated factors among HIV-infected individuals receiving highly active antiretroviral therapy in Jimma zone Southwest Ethiopia. Nutrition Journal 11: 51, 2013

Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. American Journal of Tropical Medicine and Hygiene 85(5): 934-941, 2011

Prevalence of bovine cysticercosis and hydatidosis in Jimma municipal abattoir, South West Ethiopia. Onderstepoort Journal of Veterinary Research 76(3): 323-326, 2011

Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London. Journal of Oral Pathology and Medicine 31(3): 169-174, 2002

Clinical characteristics of cataract patients with pseudoexfoliation syndrome at jimma university specialized hospital, South west ethiopia. Ethiopian Journal of Health Sciences 22(1): 1-6, 2012

Prevalence of opportunistic intestinal parasitic infection among HIV infected patients who are taking antiretroviral treatment at Jimma Health Center, Jimma, Ethiopia. European Review for Medical and Pharmacological Sciences 17(4): 513-516, 2013

Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study. Bmc Infectious Diseases 12: 39, 2012

Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients. Ethiopian Medical Journal 50(3): 221-230, 2013

Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals. Atherosclerosis 178(1): 165-172, 2004